Here are four key points:
1. Two White House officials said Mr. Azar is President Donald Trump’s top pick for the position, with one official saying Mr. Trump signed off on Mr. Azar. However, another White House official said no decision is final until the White House makes a formal announcement, according to Politico.
2. Mr. Azar spent nearly 10 years at Lilly USA, an Eli Lilly and Co. affiliate. During his career at Lilly, he spent five years as president and was charged with overseeing the company’s biomedicines division.
3. During President George W. Bush’s administration, Mr. Azar served as the deputy secretary for HHS.
4. The Post reports a Republican health policy expert said Mr. Azar’s appointment as HHS lead is “extremely far down the road.” The White House did not make an official comment to The Post.
More articles on coding and billing:
Senate reaches bipartisan deal to restore cost-sharing subsidies — 7 insights
6 steps for GI physicians to avoid a 2019 payment penalty
70%+ of physicians prefer FFS: 3 survey findings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.